Warren Buffett fit · Wonderful businesses at fair prices
Is Neurocrine Biosciences, Inc. (NBIX) a Warren Buffett Stock?
Partial Buffett fit - meets 7/9 key criteria, but with reservations.
68/100
BMixed signals
7/9 criteria passed
+10 sector-quality lift. Top-quintile within its sector on 5 of 5 quality metrics. Raw pillar score 58 → lifted to 68 before grade derivation.
Warren Buffett's Criteria, Applied to NBIX
ROIC ≥ 15%
key13.7%
Gross margin ≥ 40%
key98.2%
Owner earnings yield ≥ 5%
key4.9%
5y profitable
How NBIX Scores on Other Strategies
Live Financial Snapshot
Market cap
$15.88B
P/E (TTM)
22.6x
ROIC (TTM)
13.68%
Gross margin
98.17%
Other Warren Buffett fit reports
Frequently Asked Questions
What is NBIX's Warren Buffett fit score?
NBIX scores 68/100 on our Warren Buffett fit engine - grade B. Partial Buffett fit - meets 7/9 key criteria, but with reservations.
Does Warren Buffett actually own NBIX?
Our score is computed from financial fundamentals against Warren Buffett's published criteria. We don't claim that Warren Buffett personally owns or recommends NBIX.
How often is this score updated?
NBIX's Warren Buffett fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Warren Buffett personally owns or recommends NBIX.